RHOC and cancer: Our current work supports that the role of RhoC in metastases of certain aggressive cancers appears to be a result of intrinsic modulation of the cancer cells’ junctions and invasiveness, and potential amplification of interferon signaling; other effects on the tumor microenvironment, such as a shift in macrophage population abundance, may cooperate to produce highly aggressive phenotypes.